The task force made three recommendations for individuals ages 40 to 75 without clinical cardiovascular disease with low-density lipoprotein lower than 190 mg/dL and without known familial hypercholesterolemia:
- Individuals with an estimated 10-year cardiovascular disease event risk of 10 percent or higher and at least one risk factor are likely to have moderate benefit from a moderate-intensity statin.
- Individuals with an estimated 10-year cardiovascular disease event risk of 7.5 percent to less than 10 percent and at least one risk factor are likely to experience small net benefit from a moderate-intensity statin; clinicians should engage patients in decision-making.
- There is insufficient evidence to assess the net harms and benefits of statins in adults 76 and older, regardless of estimated 10-year cardiovascular disease event risk or risk factors.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
The task force made three recommendations for individuals ages 40 to 75 without clinical cardiovascular disease with low-density lipoprotein lower than 190 mg/dL and without known familial hypercholesterolemia:
- Individuals with an estimated 10-year cardiovascular disease event risk of 10 percent or higher and at least one risk factor are likely to have moderate benefit from a moderate-intensity statin.
- Individuals with an estimated 10-year cardiovascular disease event risk of 7.5 percent to less than 10 percent and at least one risk factor are likely to experience small net benefit from a moderate-intensity statin; clinicians should engage patients in decision-making.
- There is insufficient evidence to assess the net harms and benefits of statins in adults 76 and older, regardless of estimated 10-year cardiovascular disease event risk or risk factors.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
